Introduction: Genetic polymorphisms of certain classes of glutathione S-transferase (GST), the enzyme responsible for the biotransformation of drugs and xenobiotics, have been associated with the risk of several cancers such as cervical cancer. The objective of this study was to characterize the impact of the rs1695 polymorphism of GSTP1 in women infected by high-risk human papillomavirus (HR-HPV) in Ouagadougou, Burkina Faso. Methods: Genotyping of GSTP1 rs1695 polymorphisms was performed in 55 women with high-risk HPV infection, and 89 healthy controls using the PCR-RFLP method. Conventional PCR was used for DNA amplification and the enzymes Alw26I or BsmA1 were used for enzymatic digestion. Results: The prevalence of GSTP1 rs1695 AA, AG and GG genotypes was respectively 27.8%, 45.8% and 26.4% in the study population with a mutation rate of 49.31%. However, the frequency of AA, AG and GG genotypic was respectively 30.3%, 45%, 24.7% in controls and 23.6%, 47.3%, 29.1% in cases. Conclusion: Our study allowed us to characterize the frequencies of GSTP1 rs1695 genotypes in the study population, in cases and controls. From our analysis, none of the three genotypes of GSTP1 rs1695 weren’t associated with a risk or a protective factor for HR-HPV infection in women in Burkina Faso.
References
[1]
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D.M., Piñeros, M., Znaor, A., et al. (2021) Cancer Statistics for the Year 2020: An Overview. International Journal of Cancer, 149, 778-789. https://doi.org/10.1002/ijc.33588
[2]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[3]
Marie Tebeu, P., Saint Saba Antaon, J., Adjeba, M., Pikop, F., Tsuala Fouogue, J. and Ndom, P. (2021) Connaissances, attitudes et pratiques des professionnels de santé sur le cancer du col de l’utérus au Cameroun. Santé Publique, 32, 489-496. https://doi.org/10.3917/spub.205.0489
[4]
Settheetham‐Ishida, W., Kanjanavirojkul, N., Kularbkaew, C. and Ishida, T. (2005) Human Papillomavirus Genotypes and the p53 Codon 72 Polymorphism in Cervical Cancer of Northeastern Thailand. Microbiology and Immunology, 49, 417-421. https://doi.org/10.1111/j.1348-0421.2005.tb03745.x
[5]
Settheetham-Ishida, W., Singto, Y., Yuenyao, P., Tassaneeyakul, W., Kanjanavirojkul, N. and Ishida, T. (2004) Contribution of Epigenetic Risk Factors but Not P53 Codon 72 Polymorphism to the Development of Cervical Cancer in Northeastern Thailand. Cancer Letters, 210, 205-211. https://doi.org/10.1016/j.canlet.2004.03.039
[6]
Zohoncon, T.M., Djigma, W.F., Karim, A., Traore, I.M.A., Ouedraogo, R.A., Traoré, E.M.A., et al. (2020) Mapping of Fourteen High-Risk Human Papillomavirus Genotypes by Molecular Detection in Sexually Active Women in the West African Sub-Region.
[7]
Kiran, B., Karkucak, M., Ozan, H., Yakut, T., Ozerkan, K., Sag, S., et al. (2010) GST (GSTM1, GSTT1, and GSTP1) Polymorphisms in the Genetic Susceptibility of Turkish Patients to Cervical Cancer. Journal of Gynecologic Oncology, 21, 169-173. https://doi.org/10.3802/jgo.2010.21.3.169
[8]
Settheetham-Ishida, W., Wongpratate, M., Phuthong, S., Natphopsuk, S. and Ishida, T. (2020) Genetic Polymorphism of Glutathione S-Transferase and Cervical Cancer Susceptibility in Northeastern Thailand. Asian Pacific Journal of Cancer Biology, 5, 35-41. https://doi.org/10.31557/apjcb.2020.5.2.35-41
[9]
Sharma, A., Pandey, A., Sharma, S., Chatterjee, I., Mehrotra, R., Sehgal, A., et al. (2014) Genetic Polymorphism of Glutathione S-Transferase P1 (GSTP1) in Delhi Population and Comparison with Other Global Populations. Meta Gene, 2, 134-142. https://doi.org/10.1016/j.mgene.2013.12.003
[10]
Zhao, E., Hu, K. and Zhao, Y. (2017) Associations of the Glutathione S-Transferase P1 Ile105Val Genetic Polymorphism with Gynecological Cancer Susceptibility: A Meta-Analysis. Oncotarget, 8, 41734-41739. https://doi.org/10.18632/oncotarget.16764
[11]
Jee, S.H., Lee, J.E., Kim, S., Kim, J.H., Um, S.J., Lee, S.J., et al. (2002) GSTP1 Polymorphism, Cigarette Smoking and Cervical Cancer Risk in Korean Women. Yonsei Medical Journal, 43, 712-716. https://doi.org/10.3349/ymj.2002.43.6.712
[12]
Nascimento, M.B.D., Treco, I.C., Lazarotto, A.K., Pascotto, C.R., Treco, F.R. and Lucio, L.C. (2024) Association between GSTP1 (rs1695) Polymorphism and Susceptibility to Human Papillomavirus (HPV) Infection in Women from Southern Brazil: A Case-Control Study. Journal of Advances in Medicine and Medical Research, 36, 145-156. https://doi.org/10.9734/jammr/2024/v36i95564
[13]
Mileo, A.M., Abbruzzese, C., Mattarocci, S., Bellacchio, E., Pisano, P., Federico, A., et al. (2009) Human Papillomavirus-16 E7 Interacts with Glutathione S-Transferase P1 and Enhances Its Role in Cell Survival. PLOS ONE, 4, e7254. https://doi.org/10.1371/journal.pone.0007254
[14]
Traore, M.A.E., Setor, A., Ouattara, A.K., Sorgho, P.A., Bado, P., Gomina, M., et al. (2019) MSPI Polymorphisms (Rs4646903) of the Cyp1a1 Gene in Women Infected with Human Papillomavirus in West Africa. International Journal of Current Research, 11, 7.
[15]
Ouedraogo, R.A., Zohoncon, T.M., Guigma, S.P., Angèle Traore, I.M., Ouattara, A.K., Ouedraogo, M., et al. (2018) Oncogenic Human Papillomavirus Infection and Genotypes Characterization among Sexually Active Women in Tenkodogo at Burkina Faso, West Africa. Papillomavirus Research, 6, 22-26. https://doi.org/10.1016/j.pvr.2018.09.001
[16]
Ouedraogo, R.A., Zohoncon, T.M., Ouattara, A.K. and Simpore, J. (2020) Prédominance du papillomavirus humain 56 dans une sous-population de femmes sexuellement actives à Garango, Centre-Est, Burkina Faso. Journal of Applied Biosciences, 150, 15499-15509. https://doi.org/10.35759/jabs.150.10
[17]
Zohoncon, T.M., Ouedraogo, T.C., Brun, L.V.C., Obiri-Yebo, D., Djigma, W.F., Kabibou, S., et al. (2016) Molecular Epidemiology of High-Risk Human Papillomavirus in High-Grade Cervical Intraepithelial Neoplasia and in Cervical Cancer in Parakou, Republic of Benin. Pakistan Journal of Biological Sciences, 19, 49-56. https://doi.org/10.3923/pjbs.2016.49.56
[18]
Zohoncon, T.M. and Simpore, J. (2013) Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso). Mediterranean Journal of Hematology and Infectious Diseases, 5, e2013059. https://doi.org/10.4084/mjhid.2013.059
[19]
Djigma, F.W., Ouédraogo, C., Karou, D.S., Sagna, T., Bisseye, C., Zeba, M., et al. (2011) Prevalence and Genotype Characterization of Human Papillomaviruses among HIV-Seropositive in Ouagadougou, Burkina Faso. Acta Tropica, 117, 202-206. https://doi.org/10.1016/j.actatropica.2010.12.007
[20]
Ouédraogo, C.M.R., Rahimy, R.M.L., Zohoncon, T.M., Djigma, F.W., Yonli, A.T., Ouermi, D., et al. (2015) Épidémiologie et caractérisation des génotypes à haut risque de Papillomavirus humain dans une population d’adolescentes sexuellement actives à Ouagadougou. Journal de GynécologieObstétrique et Biologie de la Reproduction, 44, 715-722. https://doi.org/10.1016/j.jgyn.2014.12.021
[21]
Kassogue, Y., Diakite, B., Kassogue, O., Konate, I., Tamboura, K., Diarra, Z., et al. (2019) Genetic Polymorphism of Drug Metabolism Enzymes (GSTM1, GSTT1 and GSTP1) in the Healthy Malian Population. Molecular Biology Reports, 47, 393-400. https://doi.org/10.1007/s11033-019-05143-5
[22]
Cho, H., Lee, S., Ki, C. and Kim, J. (2005) GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population. Journal of Korean Medical Science, 20, 1089-1092. https://doi.org/10.3346/jkms.2005.20.6.1089
[23]
Palma, S., Novelli, F., Padua, L., Venuti, A., Prignano, G., Mariani, L., et al. (2010) Interaction between Glutathione-S-Transferase Polymorphisms, Smoking Habit, and HPV Infection in Cervical Cancer Risk. Journal of Cancer Research and Clinical Oncology, 136, 1101-1109. https://doi.org/10.1007/s00432-009-0757-3
[24]
Saleh, R., Musa, H.H., Hamid, G.A. and Hamid, M.M.A. (2019) Frequencies of GSTP1 (Ile105Val) Polymorphism and Its Association with Acute Lymphoblastic Leukemia in Yemeni Patients. East African Scholars Publisher.
[25]
Hayes, J.D. and Pulford, D.J. (1995) The Glut Athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the Lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I. Critical Reviews in Biochemistry and Molecular Biology, 30, 445-520. https://doi.org/10.3109/10409239509083491
[26]
Tian, S., Yang, X., Zhang, L., Zhao, J., Pei, M., Yu, Y., et al. (2019) Polymorphic Variants Conferring Genetic Risk to Cervical Lesions Support GSTs as Important Associated Loci. Medicine, 98, e17487. https://doi.org/10.1097/md.0000000000017487
